HENNION & WALSH ASSET MANAGEMENT, INC. – Enanta Pharmaceuticals, Inc. Transaction History
HENNION & WALSH ASSET MANAGEMENT, INC. portfolio value:
$3.64M
portfolio value
HENNION & WALSH ASSET MANAGEMENT, INC. quarter portfolio value change:
+9.73%
quarter
Enanta Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -9.17% | -7.09K shares | -12K | $51.87 | 70.32K |
Q2 2022 | share | Decrease | -25.91% | -27.07K shares | -3.77M | $47.27 | 77.42K |
Q1 2022 | share | Increase | +2.38% | 2.43K shares | -194K | $71.18 | 104.49K |
Q4 2021 | share | Decrease | -15.12% | -18.17K shares | 801K | $74.57 | 102.06K |
Q3 2021 | share | Decrease | -3.33% | -4.14K shares | 1.35M | $56.81 | 120.24K |
Q2 2021 | share | Increase | +9.16% | 10.44K shares | -146K | $44.01 | 124.38K |
Q1 2021 | share | Increase | 0.00% | 113.94K shares | 5.62M | $49.32 | 113.94K |